VEGFA and age-related macular degeneration: Current clinical AMD therapy includes lifestyle improvements (e.g., caloric restriction and moderate exercise) as well as pharmacological treatments [e.g., antioxidants (D Aloisio et al., 2022), tyrosine kinase inhibitors (Das et al., 2023), antidiabetic drugs (Thee et al., 2021; Mauschitz et al., 2022), anti-vascular endothelial growth factor (anti-VEGF), and other therapies (Francisco and Rowan, 2023; Servillo et al., 2023; Szigiato et al., 2023)].